glp 1 and osteoporosis Frontiers The Impact of GLP1 Agonists
Description
A new study uncovered an association between glucagon-like peptide-1 receptor agonist (GLP-1RAs) use and an increased risk of gastroparesis (GP) among patients with Type 2 diabetes.
The menu, dubbed the GLP-1 (glucagon-like peptide-1) Support Menu, features five smoothies packed with fiber and protein and no added sugar to support nutritional needs
Eligibility criteria Adults (18 years) receiving any approved GLP-1 RA for any indication
When it comes to science-backed weight loss and metabolic health, GLP-1 & GIP are leading the charge
Compare early results with Wegovy and Mounjaro.
Conclusion The current evidence suggests a possible association between use of GLP-1RA and an increased risk of depression, but overall risk seems to be dominated by population characteristics, drug class, and how mood outcomes are assessed
